Nav1.1 Sodium Channel Protein

Nav1.1 Sodium Channel Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Nav1.1 Sodium Channel Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NAV1-1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Nav1.1 Sodium Channel</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=NAV1-1" target="_blank">Search UniProt</a></td>
</tr>
</table>

Nav1.1 is a voltage-gated sodium channel alpha subunit encoded by SCN1A. In the adult brain, Nav1.1 is enriched in fast-spiking inhibitory interneurons, where it supports high-frequency firing and stabilizes excitation-inhibition balance in cortical and hippocampal circuits.[@claes2001][@ogiwara2007] Reduced Nav1.1 function is strongly linked to epileptic encephalopathies, while network-level Nav1.1 deficits are also relevant to cognitive circuit dysfunction seen in neurodegeneration-associated hyperexcitability.[@ogiwara2007][@verret2012]

Molecular Architecture and Biophysics

Like other Nav alpha subunits, Nav1.1 contains four homologous domains (DI-DIV), each with six transmembrane segments (S1-S6). The S4 segments form voltage sensors, while S5-S6 loops shape the sodium-selective pore.[@catterall2012] Fast inactivation is mediated by the intracellular DIII-DIV linker, which rapidly limits inward sodium current after channel opening.[@catterall2012]

Key functional properties include:

Nav1.1 Sodium Channel Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Nav1.1 Sodium Channel Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NAV1-1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Nav1.1 Sodium Channel</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=NAV1-1" target="_blank">Search UniProt</a></td>
</tr>
</table>

Nav1.1 is a voltage-gated sodium channel alpha subunit encoded by SCN1A. In the adult brain, Nav1.1 is enriched in fast-spiking inhibitory interneurons, where it supports high-frequency firing and stabilizes excitation-inhibition balance in cortical and hippocampal circuits.[@claes2001][@ogiwara2007] Reduced Nav1.1 function is strongly linked to epileptic encephalopathies, while network-level Nav1.1 deficits are also relevant to cognitive circuit dysfunction seen in neurodegeneration-associated hyperexcitability.[@ogiwara2007][@verret2012]

Molecular Architecture and Biophysics

Like other Nav alpha subunits, Nav1.1 contains four homologous domains (DI-DIV), each with six transmembrane segments (S1-S6). The S4 segments form voltage sensors, while S5-S6 loops shape the sodium-selective pore.[@catterall2012] Fast inactivation is mediated by the intracellular DIII-DIV linker, which rapidly limits inward sodium current after channel opening.[@catterall2012]

Key functional properties include:

• Low activation threshold that supports rapid spike initiation.
• Fast activation and inactivation kinetics for repetitive firing.
• Recovery-from-inactivation dynamics that constrain interneuron firing precision under sustained input.[@catterall2012][@catterall2005]

Physiologic Role in Neural Circuits

Nav1.1 is critical for parvalbumin-positive and somatostatin-positive interneuron excitability. Interneuron hypoexcitability from Nav1.1 loss-of-function weakens feedforward and feedback inhibition, increasing pathological synchrony and seizure susceptibility.[@ogiwara2007][@yu2006]

Circuit consequences include:

• Reduced gamma oscillation fidelity.
• Impaired temporal coordination of pyramidal neuron firing.
• Increased vulnerability to runaway excitation under inflammatory or metabolic stress.[@ogiwara2007][@yu2006]

Disease Relevance

Dravet Syndrome and Related SCN1A Disorders

Haploinsufficiency and other loss-of-function variants in SCN1A cause Dravet syndrome and related developmental and epileptic encephalopathies.[@claes2001][@mantegazza2015] The core mechanism is inhibitory interneuron failure rather than primary pyramidal-cell hyperactivity, which explains why non-selective sodium channel blockers can worsen seizures in some patients.[@yu2006][@mantegazza2015]

Alzheimer's Disease and Network Hyperexcitability

Experimental work indicates that interneuron dysfunction can drive network hypersynchrony in Alzheimer's models, with Nav1.1 insufficiency as one mechanistic contributor.[@verret2012] This maps onto clinical observations of subclinical epileptiform activity in some patients with Alzheimer's disease.

Broader Neurodegeneration Context

Although Nav1.1 is not a canonical proteinopathy driver, inhibitory-circuit fragility intersects with [tau](/proteins/tau)- and amyloid-linked network dysfunction. Nav1.1 therefore sits at a mechanistic interface between ion-channel excitability control and degenerative network collapse.[@verret2012][@catterall2012]

Therapeutic Strategies

Precision Channelopathy Approaches

• SCN1A-directed gene replacement and enhancer strategies are under active development.
• Antisense and transcriptional upregulation approaches aim to raise functional Nav1.1 expression in inhibitory [neurons](/entities/neurons).[@mantegazza2015][@han2020]

Symptomatic Network Stabilization

• Dravet-focused regimens use agents that avoid worsening sodium-channel inhibition in susceptible genotypes.
• Adjunct strategies target GABAergic tone and seizure-threshold stabilization while disease-modifying methods are pursued.[@mantegazza2015][@han2020]

Relevance to Neurodegenerative Care

In selected [Alzheimer's disease](/diseases/alzheimers-disease) contexts with epileptiform activity, understanding interneuron sodium-channel biology may help frame biomarker-guided antiseizure choices and trial stratification.[@verret2012]

Evidence and Open Questions

Strong evidence supports Nav1.1 involvement in monogenic epileptic encephalopathy. Evidence in neurodegeneration is biologically plausible but less direct and remains translational.[@verret2012][@mantegazza2015]

Open questions:

• Which patient subsets with neurodegeneration show Nav1.1-dominant inhibitory failure?
• Can EEG phenotyping or interneuron-linked biomarkers identify responders to circuit-targeted therapy?
• What safety profile is acceptable for chronic Nav1.1 augmentation in older adults with multimorbidity?

See Also

• [Nav1.3 Protein](/proteins/nav1-3)
• [Nav1.6 Protein (SCN8A)](/proteins/nav1-6-protein)
• [Neuronal Hyperexcitability Pathway](/mechanisms/neuronal-excitability-pathway)
• [Excitotoxicity Pathway](/mechanisms/excitotoxicity-pathway)
• [Alzheimer's Disease](/diseases/alzheimers-disease)

External Links

• [UniProt P35498](https://www.uniprot.org/uniprotkb/P35498/entry)
• [NCBI Gene: SCN1A](https://www.ncbi.nlm.nih.gov/gene/6323)

Brain Atlas Resources

• [Allen Human Brain Atlas - Nav1.1 Expression](https://human.brain-map.org/microarray/search/show?search_term=Nav1.1)
• [Allen Cell Type Atlas - Nav1.1](https://celltypes.brain-map.org/)
• [BrainSpan - Nav1.1 Developmental Expression](https://brainspan.org/)
• [Allen Mouse Brain Atlas - Nav1.1](https://mouse.brain-map.org/)

References